Wiggermann V, Hernández-Torres E, Traboulsee A, Li DK, Rauscher A. FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion Detection. AJNR Am J Neuroradiol. 2016;37(2):259-265.

FLAIR, T2-weighted and PD sequences show MS lesions as hyperintesities. Gadolinium-enhancing postcontrast T1-weighted images of MS foci indicate disruption of the blood-brain barrier and are ...

As the authors further wrote, “Multiple sclerosis (MS) is a chronic disabling disease affecting over 2.8 million people worldwide, ... T2-weighted, and T2-FLAIR contrasts) ...

Relapsing-remitting MS is a form of the disease marked by symptom flare-ups followed by periods of remission. For the two-year study, researchers enrolled 85 people who had relapsing-remitting MS ...

Of the participants analyzed, 47% were diagnosed with MS. Of these, all but 2 had relapsing-remitting MS. Central nervous system sensory symptoms were the most frequent presentations (40.5% ...

Additionally, MindGlide was better than standard tools in quantifying the differences in lesion volume between treatment and placebo groups in the primary progressive MS trial, with 5.31% in FLAIR ...

A blood test to monitor a nerve protein in the blood of people with multiple sclerosis (MS) may help predict whether disease activity is flaring up, according to a study published in the Nov. 29 ...